Purchase Order 75N98026P01289

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $1,056,500 delivery order to Curia Global Inc., doing business as Amri, under the prime contractor's Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity master contract. The delivery order is for the manufacture of MBX-400, with work to be performed by Amri in Albany, New York between...

The National Institute on Drug Abuse (NIDA), on behalf of the National Institute of Neurological Disorders and Stroke (NINDS), issued a purchase order to Curia Global Inc. (doing business as Amri) on September 19, 2024, for non-GMP synthesis of compounds, with a ceiling value of $1,785,511.20. The order supports a medicinal chemistry discovery program focused on identifying molecules that bind the KIAA0203 protein for potential Alzheimer's drug development. Work is performed in Buffalo, New...

This is a federal contract award to Curia Global Inc., doing business as Amri, by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke. The contract, valued at $3,360,769.23, is for the Medicinal Chemistry Support Program for Therapeutic Development (MCSP-EC), which involves exploratory chemistry services. The contract has a completion date of November 13, 2025 and was awarded on May 6, 2022. Curia Global is a...

The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $1,297,587.74 cost-plus-fixed-fee delivery order to Curia Global Inc. (doing business as Amri) for the Medicinal Chemistry Support Program for Therapeutic Development. This program supports medicinal chemistry and other drug discovery and development services to advance treatments for conditions such as Alzheimer's disease, Parkinson's disease, pain, substance abuse, and...

This is a federal contract award to Curia Global Inc., doing business as Amri, a leading global contract development and manufacturing organization (CDMO). The award, with a ceiling value of $2,755,155.31, was issued by the National Institute of Neurological Disorders and Stroke (NINDS), a civilian agency, under the Drug Manufacturing and Formulation Program (DMFP) indefinite-delivery/indefinite-quantity (IDIQ) contract. The contract is a delivery order and has a pricing type of cost plus...

The National Institute of Neurological Disorders and Stroke awarded a purchase order to Araldi Gian Luca for medicinal chemistry consulting services and bioactivity assay development consulting services on September 29, 2025, with a ceiling value of $37,600. The order is designated a Total Small Business set-aside. Performance is located in San Marcos, California, with an ultimate completion date of September 28, 2026. Work supports the NIH Blueprint Neurotherapeutics Network drug discovery...

The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases (HHS-NIH-NIAID) awarded a $443,000 delivery order against the Nonclinical Services for Development of Interventional Agents indefinite-delivery/indefinite-quantity (IDIQ) multiple award contract to Curia Global Inc., doing business as Amri. This firm fixed price order is for non-clinical services and will be performed in Spain from September 14, 2022 through December...

This is a federal contract award issued by the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH), to Curia Global Inc. (doing business as Amri). The contract is part of the Medicinal Chemistry Support Program for Therapeutic Development (MCSP) and has a task order number of NIH-NINDS-20-03. The contract is focused on "Medicinal Chemistry Support Program for Therapeutic Development" and specifically on the "BASE EC (PAIN)"...

This is a delivery order task order awarded by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services (HHS), to Curia Global Inc. (doing business as Amri). The task order, valued at $215,934.00, is for the Medicinal Chemistry Support Program for Therapeutic Development (MCSP), which provides medicinal chemistry and drug discovery services to support NIDA's research initiatives. The contract is a firm-fixed-price delivery order...

This federal contract award to Curia Global Inc., doing business as AMRI, is for chemistry and manufacturing services related to the chemical synthesis and process optimization of the compound STF-1759. The award was made by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services. The contract has a ceiling value of $411,404.73 and a period of performance through September 30, 2021. It is a cost-plus-fixed-fee...